Figure 3
Mean concentrations (plus s.d.) of ifosfamide administered alone (closed symbols, bars up) or in combination with pazopanib (open symbols, bars down) during 3 consecutive bolus infusion days.
Figure 3 | British Journal of Cancer
Mean concentrations (plus s.d.) of ifosfamide administered alone (closed symbols, bars up) or in combination with pazopanib (open symbols, bars down) during 3 consecutive bolus infusion days.
